// company-profile

Corvus Pharmaceuticals, Inc.

CRVS
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings54Insiders15
// api This Corvus Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares (net $250K). Buying was led by Moore David Scott.

// 90-day insight

Over the last 90 days, Corvus Pharmaceuticals, Inc. insiders bought $334K across 9 transactions with no open-market sales.

  • Most active insider: Moore David Scott with 2 transactions totaling $250K.
  • Largest single purchase: $250K by Moore David Scott on Jun 11, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Corvus Pharmaceuticals, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$983.4M
QoQ change
+199.7%
Reporting period
2026-03-31
#1
ORBIMED ADVISORS LLC
CIK 1055951
$104.8M
7.2M shares
#2
STATE STREET CORP
CIK 93751
$52.2M
3.6M shares
#3
ADAMS STREET PARTNERS LLC
CIK 1193586
$47.9M
3.3M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 11, 2026Moore David ScottCRVS
Purchase
21,700$11.53$250K
Jun 11, 2026CLARK IAN TCRVS
Award
15,000$0.00$0K
Jun 11, 2026Moore David ScottCRVS
Award
15,000$0.00$0K
Jun 11, 2026van den Broek RichardCRVS
Award
15,000$0.00$0K
Jun 11, 2026Thompson Peter A.CRVS
Award
15,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.